Table 3.
Treatment group | Standard (n = 37) | SIB (n = 22) | P-value | |||||||||
Diarrhea | G1 | 20 (54.1%) | 13 (59.1%) | 0.706 | G2 | 16 (43.2%) | 9 (40.9%) | 0.861 | G3 | 1 (2.7%) | 0 (0.0%) | 0.437 |
Cystitis | G1 | 25 (67.6%) | 14 (63.6%) | 0.758 | G2 | 9 (24.3%) | 5 (22.7%) | 0.889 | G3 | 3 (8.1%) | 3 (13.6%) | 0.497 |
Dermatitis | G1 | 15 (40.5%) | 10 (45.5%) | 0.712 | G2 | 18 (48.6%) | 10 (45.5%) | 0.812 | G3 | 4 (10.8%) | 2 (9.1%) | 0.833 |
Acute toxicities according to Common Terminology Criteria for Adverse Events (CTCAE), version 3.0, 2003. G1 (Grade 1) - Mild AE, G2 (Grade 2) - Moderate AE, G3 (Grade 3) - Severe AE.